Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
March 11, 2021
Deceased-Donor Acute Kidney Injury and BK Polyomavirus in Kidney Transplant Recipients
Isaac E Hall, Peter Philip Reese, Sherry G Mansour, et al.
Journal of the National Cancer Institute. Monographs
|
June 26, 2024
Transforming patient-centered cancer care using telehealth: the MATCHES Center
Erin M Bange, Robert M Daly, Allison Lipitz-Snyderman, et al.
Experimental Hematology
|
October 17, 2001
Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways
P D Doshi, J G Giri, A L Abegg, et al.
Transplantation
|
October 1, 2019
Urine Injury Biomarkers Are Not Associated With Kidney Transplant Failure
Neel Koyawala, Peter P Reese, Isaac E Hall, et al.
Kidney International
|
November 25, 2018
Deceased-donor acute kidney injury is not associated with kidney allograft failure
Isaac E Hall, Enver Akalin, Jonathan S Bromberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 3, 2022
Deceased-Donor Acute Kidney Injury and Acute Rejection in Kidney Transplant Recipients: A Multicenter Cohort
Peter P Reese, Mona D Doshi, Isaac E Hall, et al.
Kidney360
|
April 4, 2022
Post-transplant Diabetes Mellitus in Kidney Transplant Recipients: A Multicenter Study
Rubab F Malik, Yaqi Jia, Sherry G Mansour, et al.
European Urology Oncology
|
November 9, 2023
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
BMC Nephrology
|
January 13, 2021
Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
Sami Alasfar, Isaac E Hall, Sherry G Mansour, et al.
European Urology Oncology
|
March 30, 2025
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
Clinical Journal of the American Society of Nephrology : CJASN
|
March 11, 2021
Deceased-Donor Acute Kidney Injury and BK Polyomavirus in Kidney Transplant Recipients
Isaac E Hall, Peter Philip Reese, Sherry G Mansour, et al.
Journal of the National Cancer Institute. Monographs
|
June 26, 2024
Transforming patient-centered cancer care using telehealth: the MATCHES Center
Erin M Bange, Robert M Daly, Allison Lipitz-Snyderman, et al.
Experimental Hematology
|
October 17, 2001
Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways
P D Doshi, J G Giri, A L Abegg, et al.
Transplantation
|
October 1, 2019
Urine Injury Biomarkers Are Not Associated With Kidney Transplant Failure
Neel Koyawala, Peter P Reese, Isaac E Hall, et al.
Kidney International
|
November 25, 2018
Deceased-donor acute kidney injury is not associated with kidney allograft failure
Isaac E Hall, Enver Akalin, Jonathan S Bromberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 3, 2022
Deceased-Donor Acute Kidney Injury and Acute Rejection in Kidney Transplant Recipients: A Multicenter Cohort
Peter P Reese, Mona D Doshi, Isaac E Hall, et al.
Kidney360
|
April 4, 2022
Post-transplant Diabetes Mellitus in Kidney Transplant Recipients: A Multicenter Study
Rubab F Malik, Yaqi Jia, Sherry G Mansour, et al.
European Urology Oncology
|
November 9, 2023
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
BMC Nephrology
|
January 13, 2021
Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
Sami Alasfar, Isaac E Hall, Sherry G Mansour, et al.
European Urology Oncology
|
March 30, 2025
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
Page
of 14